HYNIC-3PRGD2

甲苯磺酸钠烟酰胺腙聚乙二醇双环RGD肽

Report date: 2026/04/15 20:02:38
NME

Base Information

Drug NameHYNIC-3PRGD2
Drug Alias Name注射用甲苯磺酸钠烟酰胺腙聚乙二醇双环RGD肽注射用锝[⁹⁹ᵐTc]佩昔瑞特加肽药盒
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin alpha-V/beta-3 modulators
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsContrast agentsDiagnostic agentsExtranodal Extension +[5] 
Global Approved IndicationsContrast agentsDiagnostic agentsExtranodal Extension +[4] 
Approved Indications in ChinaContrast agentsDiagnostic agentsExtranodal Extension +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date2026/03/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFoshan Rui Diao Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFoshan Rui Diao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsContrast agentsDiagnostic agentsExtranodal Extension +[4] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A